Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)
Timothy Go Elected to Celanese Board of Directors
Celanese Corporation Reports Full Year 2023 and Fourth Quarter Earnings
Celanese Low-Carbon ECO-CC Products Available Through U.S. Department of Energy Procurement Grant Program
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
Celanese and Under Armour Develop Innovative New NEOLAST™ Fiber for Use in Performance Stretch Fabrics
Celanese to Hold Fourth Quarter Earnings Conference Call on February 21, 2024
Celanese Begins Carbon Capture and Utilization Operations at Clear Lake, Texas, Facility
Celanese Corporation Reports Third Quarter 2023 Earnings